BCL2 and invasive breast carcinoma: THSWD combined with chemotherapy drugs in the treatment of invasive breast cancer can promote tumor cell apoptosis by down-regulating Bcl-2 protein, up-regulating Bax protein, and reducing Bcl-2/Bax ratio.